Babylon
The deal is expected to close in the second half of 2021 and be worth roughly $4.2 billion.
According to Business Insider, the pair made a $70 million licensing deal.
Also: Oscar Health IPO dips below expectations; DrChrono's new "all-in-one telehealth app experience."
The funds are to continue the UK health tech firm’s international expansion.
New report compares symptom assessment apps on condition coverage, accuracy and safety.
The project has received funding from the Bill & Melinda Gates Foundation.
The smartphone blood testing service is one of just a handful of SMEs selected for annual programme to transform the NHS.
Researchers used causal machine learning approach to increase algorithm’s accuracy.
As part of the deal, Babylon's symptom checker tech will be integrated into Higi's Smart Health Stations.
The tests give users the option to share information to aid national research into the virus.